# Study of Cabazitaxel Combined With Prednisone and Prophylaxis of Neutropenia Complications in the Treatment of Patients With Metastatic Castration-resistant Prostate Cancer

> **NCT01649635** · PHASE4 · COMPLETED · sponsor: **Sanofi** · enrollment: 45 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** CABAZITAXEL (XRP6258)
- **DRUG:** Prednisone
- **DRUG:** Ciprofloxacin
- **DRUG:** G-CSF (Granulocyte colony-stimulating factor)

## Key facts

- **NCT ID:** NCT01649635
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2014-01
- **Final completion:** 2016-06
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2016-07-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01649635

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01649635, "Study of Cabazitaxel Combined With Prednisone and Prophylaxis of Neutropenia Complications in the Treatment of Patients With Metastatic Castration-resistant Prostate Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01649635. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*